CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-03 | El-Hibri Fuad Director | Other acquisition | +3,018,644 | 3,018,644 | ||
| 2021-12-03 | El-Hibri Fuad Director | Other acquisition | +274,930 | 274,930 | ||
| 2021-12-03 | El-Hibri Fuad Director | Other acquisition | +206,434 | 206,434 | ||
| 2021-11-15 | LINDAHL RICHARD S EVP, Chief Financial Officer | Purchase | +3,000 | $37.46 | $112K | 39,919 |
| 2021-05-25 | Zoon Kathryn C Director | Sale | −3,139 | $56.48 | $177K | 14,377 |
| 2021-05-20 | SULLIVAN LOUIS W Director | Grant or award | +5,027 | 44,972 | ||
| 2021-05-20 | Zoon Kathryn C Director | Grant or award | +5,027 | 17,516 | ||
| 2021-05-20 | Harsanyi Zsolt Director | Grant or award | +5,027 | 29,606 | ||
| 2021-05-20 | Richard Ronald Director | Grant or award | +5,027 | 13,303 | ||
| 2021-05-20 | JOULWAN GEORGE A Director | Grant or award | +5,027 | 31,798 | ||
| 2021-05-20 | White Marvin L Director | Grant or award | +5,027 | 8,656 | ||
| 2021-05-20 | Hauer Jerome M Director | Grant or award | +5,027 | 15,215 | ||
| 2021-05-10 | SULLIVAN LOUIS W Director | Option exercise | +10,305 | $18.64 | $192K | 43,063 |
| 2021-05-10 | SULLIVAN LOUIS W Director | Shares withheld for taxes | −3,118 | $61.62 | $192K | 39,945 |
| 2021-05-10 | SULLIVAN LOUIS W Director | Option exercise · Employee Stock Options (Right to Buy) | −10,305 | 0 | ||
| 2021-05-08 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −1,054 | $61.62 | $65K | 36,919 |
| 2021-05-08 | Kramer Robert President and CEO | Shares withheld for taxes | −94 | $61.62 | $6K | 163,053 |
| 2021-05-07 | Smith Karen L. EVP, Chief Medical Officer | Shares withheld for taxes | −305 | $60.85 | $19K | 11,888 |
| 2021-03-31 | Kirk Sean EVP, Manufacturing & Tech Ops | Shares withheld for taxes | −159 | 17,776 | ||
| 2021-03-04 | Bailey Sue Director | Sale | −8,168 | $92.37 | $754K | 24,427 |
Page 18 of 31 · 601 trades